AI-Enabled Marketing Transformation in the Indian Pharmaceutical Sector

Authors

  • M. Venkatesulu

Keywords:

Artificial Intelligence (AI), Pharmaceutical Marketing, Digital Transformation, Indian Pharmaceutical Sector, Machine Learning, Predictive Analytics, Customer Relationship Management (CRM), Personalized Marketing, Healthcare Marketing, Patient-Centric Communication

Abstract

This research paper explores the impact of Artificial Intelligence (AI) on the Indian pharmaceutical industry and how it has revolutionized marketing practices. This study examines the use of AI technology like predictive analytics, machine learning, chatbots, customer relationship management systems, and customised digital marketing for improving efficiency, customer interactions, and decision-making in pharmaceutical marketing. The paper emphasizes how AI tools are increasingly being used by pharma firms to gain insights into customer behavior, increase sales efficiency, target physicians more effectively, and enhance patient engagement. It also discusses the pros and cons of using AI, such as privacy issues, ethics, technical and infrastructure requirements, and changing the way employees work. The research methodology used is an Analytical and Exploratory approach with Secondary data (Based on the Industrial Reports, Journals and Case Studies of the Indian Pharmaceuticals market). The results reveal that AI-driven marketing transformation has a proven impact on boosting operational efficiency, market responsiveness, and competitive advantage, which fosters the sustainable development and digital transformation of the pharmaceutical industry in India.

Downloads

Download data is not yet available.

References

Jacob Cohen. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Lawrence Erlbaum Associates.

Lee J. Cronbach. (1951). Coefficient alpha and the internal structure of tests. Psychometrika, 16(3), 297–334.

Ibrahim Etikan., Sani Abubakar Musa., & Rukayya Sunusi Alkassim. (2016). Comparison of convenience sampling and purposive sampling. American Journal of Theoretical and Applied Statistics, 5(1), 1–4.

Greg Guest., Emily Namey., & Marilyn Mitchell. (2013). Collecting qualitative data: A field manual for applied research. SAGE Publications. https://doi.org/10.4135/9781506374680

Robert V. Hogg., & Elliot A. Tanis. (2010). Probability and statistical inference (8th ed.). Pearson.

Christian Homburg., Michael Stierl., & Thorsten Bornemann. (2013). Corporate social responsibility in business-to-business markets: How organizational customers account for supplier corporate social responsibility engagement. Journal of Marketing, 77(6), 54–72.

IBM. (2017). IBM SPSS Statistics for Windows (Version 25.0) [Computer software]. IBM Corp.

Charles H. Lawshe. (1975). A quantitative approach to content validity. Personnel Psychology, 28(4), 563–575.

K. Madhusudhana. (2021). Role of information and promotional strategies for Indian pharmaceutical firms in the age of digital marketing. EPRA International Journal of Economics, Business and Management Studies, 9(8), 170–172. https://doi.org/10.36713/EPRA6577

Denise F. Polit., & Cheryl Tatano Beck. (2006). The content validity index: Are you sure you know what’s being reported? Critique and recommendations. Research in Nursing & Health, 29(5), 489–497.

Rachel E. Sherman., Sarah A. Anderson., Gerald J. Dal Pan., Graham W. Gray., Tina Gross., Nancy L. Hunter., et al. (2016). Real-world evidence—What is it and what can it tell us? New England Journal of Medicine, 375(23), 2293–2297.

William W. Stead., & Harold S. Lin. (Eds.). (2009). Computational technology for effective health care: Immediate steps and strategic directions. National Academies Press. https://doi.org/10.17226/12572

Downloads

Published

31.05.2024

How to Cite

M. Venkatesulu. (2024). AI-Enabled Marketing Transformation in the Indian Pharmaceutical Sector. International Journal of Intelligent Systems and Applications in Engineering, 12(20s), 1101–1106. Retrieved from https://ijisae.org/index.php/IJISAE/article/view/8314

Issue

Vol. 12 No. 20s (2024)

Section

Research Article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.

IJISAE open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.